Dr. Donald Robert Lee May is a Lubbock, Texas based male Ophthalmologist who is specialized in Ophthalmology. Active license number of Dr. Donald Robert Lee May is H8905 for Ophthalmology in Texas. Dr. Donald Robert Lee May is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Dr. Donald Robert Lee May speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
M.D.
Gender:
Male
Practice Address:
4611 9th St, Lubbock, Texas, 79416-4710
Phone:
806-543-0678
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1194086561
NPI Enumeration Date:
01 Jun, 2012
NPI Last Update On:
01 Jun, 2012
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Donald Robert Lee May are as mentioned below.
License Number
Specialization
State
Status
H8905
Ophthalmology
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Po Box 1678, Lubbock, Texas
Zip:
79408-1678
Phone Number:
806-543-0678
Fax Number:
--
Patients can reach Dr. Donald Robert Lee May at 4611 9th St, Lubbock, Texas or can call to book an appointment on 806-543-0678. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.